State Street(R) Health Care Select Sector SPDR(R) ETF
State Street(R) Health Care Select Sector SPDR(R) ETF reported 59 holdings worth US$40.6B as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 28, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF reported 59 holdings worth US$40.6B as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Aug 28, 2026 (Form N-PORT).
- Holdings
- 59
- Value as reported
- US$40.6B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 5.59M | US$6.7B | 16.5% |
| Johnson & Johnson | 17M | US$4.32B | 10.6% |
| Abbvie Inc. | 12.5M | US$3.14B | 7.7% |
| Unitedhealth Group Incorporated | 6.42M | US$2.67B | 6.6% |
| Merck & Company, Inc. | 17.4M | US$2.24B | 5.5% |
| Amgen Inc. | 3.81M | US$1.38B | 3.4% |
| Thermo Fisher Scientific Inc | 2.63M | US$1.32B | 3.2% |
| Abbott Laboratories | 12.3M | US$1.12B | 2.8% |
| Gilead Sciences, Inc. | 8.77M | US$1.11B | 2.7% |
| Intuitive Surgical, Inc. | 2.5M | US$995M | 2.5% |
| Pfizer, Inc. | 40.3M | US$970M | 2.4% |
| Cvs Health Corporation | 9.01M | US$932M | 2.3% |
| Vertex Pharmaceuticals Incorporated | 1.79M | US$891M | 2.2% |
| Danaher Corporation | 4.45M | US$848M | 2.1% |
| Bristol-myers Squibb Company | 14.4M | US$831M | 2.0% |
| Stryker Corporation | 2.44M | US$767M | 1.9% |
| Medtronic Plc. | 9.07M | US$710M | 1.7% |
| Mckesson Corporation | 849K | US$642M | 1.6% |
| Elevance Health, Inc. | 1.53M | US$593M | 1.5% |
| The Cigna Group | 1.87M | US$515M | 1.3% |
| Boston Scientific Corporation | 10.5M | US$448M | 1.1% |
| Regeneron Pharmaceuticals, Inc. | 706K | US$440M | 1.1% |
| Hca Healthcare, Inc. | 1.1M | US$428M | 1.1% |
| Cardinal Health, Inc. | 1.65M | US$393M | 0.97% |
| Cencora, Inc. | 1.37M | US$389M | 0.96% |
| Edwards Lifesciences Corporation | 4.07M | US$368M | 0.91% |
| Humana Inc. | 848K | US$337M | 0.83% |
| Becton, Dickinson And Company | 1.95M | US$295M | 0.73% |
| Idexx Laboratories, Inc. | 557K | US$293M | 0.72% |
| Agilent Technologies, Inc. | 2M | US$265M | 0.65% |
| Waters Corporation | 694K | US$260M | 0.64% |
| Iqvia Holdings, Inc. | 1.18M | US$228M | 0.56% |
| Biogen Inc. | 1.04M | US$225M | 0.56% |
| Zoetis Inc. | 2.96M | US$213M | 0.52% |
| Centene Corporation | 3.31M | US$213M | 0.52% |
| Ge Healthcare Technologies Inc. | 3.21M | US$206M | 0.51% |
| Resmed Inc. | 1.02M | US$200M | 0.49% |
| Veeva Systems Inc. | 1.06M | US$188M | 0.46% |
| Dexcom, Inc. | 2.73M | US$184M | 0.45% |
| Mettler-toledo International, Inc. | 143K | US$182M | 0.45% |
| West Pharmaceutical Services, Inc. | 499K | US$179M | 0.44% |
| Moderna, Inc. | 2.49M | US$175M | 0.43% |
| Quest Diagnostics Incorporated | 782K | US$166M | 0.41% |
| Labcorp Holdings Inc. | 579K | US$162M | 0.40% |
| Steris Plc (ireland) | 693K | US$146M | 0.36% |
| Incyte Corporation | 1.19M | US$134M | 0.33% |
| Viatris Inc. | 8.23M | US$131M | 0.32% |
| Zimmer Biomet Holdings, Inc. | 1.37M | US$118M | 0.29% |
| The Cooper Companies, Inc. | 1.38M | US$98.8M | 0.24% |
| Revvity, Inc. | 788K | US$87.7M | 0.22% |
| Solventum Corporation | 1.04M | US$80.2M | 0.20% |
| Align Technology, Inc. | 471K | US$79.4M | 0.20% |
| Bio-techne Corp | 1.11M | US$78.1M | 0.19% |
| Baxter International Inc. | 3.65M | US$77.8M | 0.19% |
| Charles River Laboratories International, Inc. | 340K | US$77.2M | 0.19% |
| Insulet Corporation | 489K | US$74.5M | 0.18% |
| Henry Schein, Inc. | 684K | US$57.1M | 0.14% |
| Universal Health Services, Inc. | 376K | US$56M | 0.14% |
| Davita Inc. | 227K | US$50.4M | 0.12% |
Source
View original at SEC
Related